Cambridge Innovation Capital has released the numbers for its performance during the first half of the financial year, boasting a rise in its portfolio's fair value to $116m.

Cambridge Innovation Capital (CIC), the patient capital fund affiliated with University of Cambridge, on Friday revealed the fair value of its portfolio has increased to £86m ($116m) during the first half of the financial year. CIC, which announced the figures for the period ending September 30, noted that the value was up from £58.2m as…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.